Navigation Links
Leading Global Clinical Research Organization chooses GBS to Support their IBM Domino Infrastructure
Date:7/29/2013

Woodstock, GA (PRWEB) July 29, 2013

GBS Enterprises Inc. (GBSX), a global software and services company specializing in Application Modernization, Mobility and Infrastructure Management announced that they have been chosen to support and maintain the IBM Domino and Notes infrastructure of one of the world’s leading clinical research firms.

The firm is known for its high performance and reputation for conducting global clinical development programs of the highest integrity. It is a leader in delivering clinical trial programs to pharmaceutical and biotechnology companies in therapeutic areas of specialty, and in innovative pediatric and women’s health trials.

With an increase in demand on critical IT resources it was an easy decision to choose GBS to manage their IBM Domino and Notes infrastructure.

“Organizations with IBM Notes and Domino infrastructure continue to have increased demand from users for improved infrastructure and support systems. Having internal IT staff spend time maintaining and supporting existing infrastructure is expensive, and as we are also hearing from many customers, prevents them from focusing on strategic and long term projects”, says Joerg Ott, CEO of GBS. “GBS’ Domino Admin Services offerings are tailored specifically for organizations running IBM Domino infrastructure to enable them to reduce cost, optimize performance and improve SLAs.”    

About GBS (GROUP Business Software)
GBS Enterprises Inc. (GBSX) is the world’s leading provider of expertise and solutions for the IBM Notes and Domino platform. GBS enables organizations with investments in Notes and Domino infrastructure to effectively respond to the rapidly evolving needs of their business users, while lowering costs and increasing returns on these investments. GBS helps customers understand and evaluate their cur-rent infrastructure and application environments, formulate strategic technology and operational goals, and implement solutions that meet current and future business needs.

GBS has over 5,000 customers with over 4 million users of its products and services. GBS resources are available at 12 locations across North America, Europe and Asia. For more information, please visit http://www.gbs.com.

Caution Concerning Forward-Looking Statements
This release contains statements that may constitute "forward-looking statements" under the Private Securities Litigation Reform Act of 1995. These statements regard the intent, belief, and expectations of the Company. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, they involve risks and uncertainties, and their results may differ materially.

Media Contact:
Michael Baum, Corporate Communications
michael(dot)baum(at)us(dot)gbs(dot)com

Read the full story at http://www.prweb.com/releases/2013/7/prweb10971777.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Leading experts on congenital muscular dystrophy convene at University of Nevada, Reno
2. Diabetes drug could treat leading cause of blindness
3. Pneumonia and preterm birth complications are the leading causes of childhood death
4. Leading health care quality expert is 2012 AcademyHealth Distinguished Investigator
5. Dr. Edmund Lipskis & Dr. Lynn Lipskis Will be Featured On New National Television Show Entitled: “Leading The Field” World Class Experts Share Their Tips & Advice
6. ACR: Medical imaging study in health affairs incomplete and potentially misleading
7. Poorly-performing hand implants unacceptable says leading medical journal
8. Leading cancer specialists from Europe and beyond recognized at ESMO 2012
9. WSU researchers discover mechanism leading from trichomoniasis to prostate cancer
10. Report: Cancer now leading cause of death in US hispanics
11. Leading stem cell scientists to focus on diabetes, eye diseases at Cedars-Sinai symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... ... prescription opioid overdose deaths now claim the lives of 62 Americans each day.(1) ... filings against drug manufacturers, distributors, pharmacies and prescribers by more than half.(2) ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... designed to recognize elevated anxiety levels in people with addiction who are served ... Smart Patch, a biosensing wearable device that monitors heart and breath rates to ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... health of individuals with HIV because it is not known to have significant ... have favorable effects to both lower cholesterol levels and dampen inflammation in the ...
(Date:4/24/2017)... ... ... Come to PAINWeekEnd (PWE) Tampa on May 20 and 21, at the ... 2-day program. , An attendee at a recent PAINWeekEnd said, "Very helpful, wish ... course entitled Ain't Misbehavin': Decreasing and Managing Pain Patient Aberrant Behavior, presented by Dr. ...
(Date:4/24/2017)... FOREST KNOLLS, Calif. (PRWEB) , ... April 24, 2017 , ... ... and health topics, but she has not found any of them to be very ... weekly actions to slowly and easily make changes in their health. It prompted her ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Vivify Health, the pioneer ... has been awarded a very significant patent for the ... to continual care via digital health.  This landmark patent ... property and further secures Vivify,s position as the leader ... 2009, was the first company to apply consumer mobile ...
(Date:4/20/2017)... April 20, 2017 Research and Markets has ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ... ... delivery technologies will rise from USD 20 Billion in 2015 to ... Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market ...
(Date:4/20/2017)... Research and Markets has announced the ... Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies ... ... was valued at US$ 7,167.6 Mn in 2015, and is ... a CAGR of 5.6% from 2016 to 2024. ...
Breaking Medicine Technology: